EDIL3 is a potential prognostic biomarker that correlates with immune infiltrates in gastric cancer.

MLA

Ke, Bin, et al. “EDIL3 Is a Potential Prognostic Biomarker That Correlates with Immune Infiltrates in Gastric Cancer.” PeerJ, vol. 11, Aug. 2023, p. e15559. EBSCOhost, https://doi.org/10.7717/peerj.15559.

APA

Ke, B., Liang, Z.-K., Li, B., Wang, X.-J., Liu, N., Liang, H., & Zhang, R.-P. (2023). EDIL3 is a potential prognostic biomarker that correlates with immune infiltrates in gastric cancer. PeerJ, 11, e15559. https://doi.org/10.7717/peerj.15559

Chicago

Ke, Bin, Zheng-Kai Liang, Bin Li, Xue-Jun Wang, Ning Liu, Han Liang, and Ru-Peng Zhang. 2023. “EDIL3 Is a Potential Prognostic Biomarker That Correlates with Immune Infiltrates in Gastric Cancer.” PeerJ 11 (August): e15559. doi:10.7717/peerj.15559.